Knight Therapeutics Inc. Announces Election of Directors
June 16, 2016 18:00 ET
|
Knight Therapeutics Inc.
MONTREAL, QUEBEC--(Marketwired - June 16, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company") announced today that each director nominee listed in the Management...
Long Zone Holdings Announces Acquisition of Knight Therapeutics Inc. Common Shares
June 02, 2016 18:30 ET
|
Long Zone Holdings Inc.
MONTREAL, QUEBEC--(Marketwired - June 2, 2016) - Long Zone Holdings Inc. ("the Corporation") announced that pursuant to a previously announced prospectus offering ("the Offering") by...
Thérapeutique Knight réalise le placement par prise ferme d'actions ordinaires précédemment annoncé, y compris l'exercice de l'option de surallocation, pour 230 millions de dollars
June 02, 2016 08:17 ET
|
Thérapeutique Knight Inc.
MONTRÉAL, CANADA--(Marketwired - 2 juin 2016) -
LE PRÉSENT COMMUNIQUÉ EST CENSÉ ÊTRE DIFFUSÉ AU CANADA UNIQUEMENT. IL NE DOIT PAS ÊTRE REMIS...
Knight Therapeutics Completes Previously Announced Bought Deal of Common Shares, Including Exercise of Over-Allotment Option, for $230 million
June 02, 2016 08:16 ET
|
Knight Therapeutics Inc.
MONTREAL, CANADA--(Marketwired - June 2, 2016) -
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...
Knight to Present at Both the National Bank Financial Quebec Conference in Montreal and the Jefferies Healthcare Conference in New York City
May 31, 2016 08:00 ET
|
Knight Therapeutics Inc.
MONTREAL, QUEBEC--(Marketwired - May 31, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Jonathan Ross...
Knight publie ses résultats du premier trimestre 2016
May 10, 2016 06:00 ET
|
Thérapeutique Knight Inc.
MONTRÉAL, CANADA--(Marketwired - 10 mai 2016) - Thérapeutique Knight inc. (TSX:GUD) (« Knight » ou la « Société »),...
Knight Reports First Quarter 2016 Results
May 10, 2016 06:00 ET
|
Knight Therapeutics Inc.
MONTREAL, CANADA--(Marketwired - May 10, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today reported...
Knight Blooms at Healthcare Investor Conference in Toronto
April 25, 2016 08:00 ET
|
Knight Therapeutics Inc.
MONTREAL, QUEBEC--(Marketwired - April 25, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Mr. Jonathan...
Knight reçoit un ADI de Santé Canada à propos d'ATryn(R)
April 25, 2016 08:00 ET
|
Thérapeutique Knight Inc.
MONTRÉAL, QUÉBEC--(Marketwired - 25 avril 2016) - Thérapeutique Knight inc. (TSX:GUD) (« Knight »), société pharmaceutique...
Knight Receives NOD from Health Canada for ATryn(R)
April 25, 2016 08:00 ET
|
Knight Therapeutics Inc.
MONTREAL, QUEBEC--(Marketwired - April 25, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that it has received...